On Invalid Date, Q32 Bio (NASDAQ: QTTB) reported Q4 2023 earnings per share (EPS) of -$4.86, up 55% year over year. Total Q32 Bio earnings for the quarter were -$16.12 million. In the same quarter last year, Q32 Bio's earnings per share (EPS) was -$10.80.
As of Q2 2024, Q32 Bio's earnings has grown year over year. Q32 Bio's earnings in the past year totalled -$112.96 million.
What is QTTB's earnings date?
Q32 Bio's earnings date is Invalid Date. Add QTTB to your watchlist to be reminded of QTTB's next earnings announcement.
What was QTTB's revenue last quarter?
On Invalid Date, Q32 Bio (NASDAQ: QTTB) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Q32 Bio's revenue was $802.00 thousand.
What was QTTB's revenue growth in the past year?
As of Q2 2024, Q32 Bio's revenue has grown -63.97% year over year. This is 215.42 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Q32 Bio's revenue in the past year totalled $1.16 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.